Scientific network

International collaborations

Laurent ABEL

  • Bruce Beutler, Department of Immunology, The Scripps Research Institute, La Jolla, USA (prédisposition génétique pyogènes)
  • Helen Chapel, University of Oxford and Oxford Radcliffe Hospital, Oxford, UK (prédisposition génétique pyogènes)
  • David Cooper, Institute of Medical Genetics, University of Wales College of Medicine, Cardiff, UK (prédisposition génétique mycobactéries, candidose)
  • Bodo Grimbacher, University College London, Londres, UK (prédisposition génétique candidose)
  • Steven Holland, National Institute of Allergy and Infectious Diseases, National Institutes of Health Bethesda, USA ((prédisposition génétique mycobactéries, pyogènes)
  • Dinakantha Kumararatne, Department of Clinical Immunology, Cambridge, UK (prédisposition génétique mycobactéries, pyogènes)
  • Xiaoxia Li, Cleveland Clinic Foundation, USA (pyogènes)
  • Desa Lilic, University of Newcastle, Newcastle, UK (prédisposition génétique candidose)
  • Anne O'Garra, National Institute for Medical Research, Londres, UK (prédisposition génétique tuberculose)
  • Peter Newburger, Departments of Pediatrics and Cancer Biology, University of Massachusetts Medical School Worcester USA ((prédisposition génétique mycobactéries)
  • Jennifer Puck, National Human Genome Research Institute, National Institutes of Health, Bethesda, USA ((prédisposition génétique mycobactéries)
  • Charles Rice, Rockefeller University, New-York, USA ((prédisposition génétique VHC)
  • - Robert Schreiber, Department of Pathology and Immunology, Center for Immunology, Washington University School of Medicine, St. Louis, USA (prédisposition génétique mycobactéries)

Corinne ANTIGNAC

  • Thomas Benzing, University of Cologne, Germany
  • Alessandra Boletta, Dulbecco Telethon Institute (DTI), Milan, Italie.
  • Lewis Cantley, Division of Signal Transduction, Harvard Medical School, Beth Israel Deaconness Center, Boston, MA, USA.
  • Richard Cerione, Department of Molecular Medicine, Cornell University, Ithaca, NY, USA
  • Stéphanie Cherqui, Scripps Institute, La Jolla, USA
  • Erik Christensen, Arrhus, Dannemark
  • Pierre Courtoy, UCL, Bruxelles, Belgique
  • Olivier Devuyst, UCL, Bruxelles, Belgique
  • Iain Drummond, Massachusetts General Hospital, Charlestown, USA
  • Brian Harfe, University of Florida, Gainesville, USA
  • Friedlhem Hildebrandt, University of Michigan, Ann Arbor, USA
  • Lawrence Holzman, University of Michigan, Ann Arbor, USA
  • Anil Karihaloo, Yale University, New Haven, CO, USA.
  • Jeffrey Kopp, NIDDK, Bethesda, USA
  • Michael McManus, University of California, San Francisco, USA
  • Jeffrey Miner, Washington University, Saint Louis, USA
  • Marcus Moeller, RWTH, Heidelberg, Germany
  • Peter Mundel, University of Miami, Miami, USA
  • Ulrich Rüther, Institut für Entwicklungs- und Molekularbiologie der Tiere (EMT), Düsseldorf, Germany
  • Franz Schaefer, Heidelberg, Germany

Alain Fischer

  • F.D. Bushamann, Philadelphie, U.S.A. Etude des sites d’intégration de vecteurs de thérapie génique
  • F. Candotti, NIH (génétique) Bethesda, U.S.A. Modèles animaux déficit immunitaire
  • R. Casella, NCI, Bethesda, U.S.A. Etude du système immunitaire
  • H. Chapel, Oxford, U.K. Activation des cellules du système immunitaire. Déficit immunitaire
  • M. Nussenzweig (Rockfeller University New-York, U.S.A.) Etude du système immunitaire (lymphocytes B)
  • A. Trasher (University College London, Institute of Child Health) Therapie génique SCID et Wilott Aldrech
  • A.Veillette, ICRM Montréal, Canada
  • D. Williams (Harvard Boston) – SCID Centre production vecteurs à Cincenatti

Equipe Stanislas Lyonnet

  • ERANET CraniRare : Pr B Wollnik (Koeln Univ., Germany), Dr N Akarsu (Hacettepe Univ., Ankara, Turquie), Dr U Kayserili (Istanbul, Turquie), Dr D Wieczorek (Essen Univ., Germany).
  • ERANET Hirschsprung disease Consortium : Dr I Ceccherini (Genoa, Itaky) ; Dr S Borrego (Barcelona, Spain).
  • European Skeletal Dysplasia Network et Eurogrow (7 partenaires européens)
  • International Hirschsprung Disease Consortium: A Chakravarti (Johns Hopkins, Baltimore, USA); C Eng (OSU, Ohio, USA) ; R Hofstra (Groningen, The Netherlands) ; I Ceccherini (Genoa, Italie) ; S Borrego (Barcelone, Espagne) ; P Tam (Hong-Kong, RPC)
  • International Network on Ciliopathies: H Dollfus (IGBMC Starsbourg), C Antignac and S Saunier (INSERM U-574, Necker), EM Valente (CSS Mendel, Roma, Italy), J Gleeson (Howard Hughes, UCSD, USA), N Katsanis (Johns Hopkins Baltimore).
  • Laboratoire International Associé (LIA) Franco-Marocain de l’INSERM : Pr A Sefiani (INH and Rabat Univ., Morocco).
  • NIH Project N°5PO1 HD39948 : Hereditary basis of Neural Tube Defects. MC Speer (PI, Duke Univ., USA), M Lovett (Washington Univ., USA).

Equipe Valérie Cormier-Daire

  • Yasemin Alanay, Hacettepe Unviersity, Ankara, Turquie
  • Skeletal Dysplasia Registry, Cedars Sinai Medical Center, (Head : David Rimoin), Los Angeles, USA
  • Stephen. Robertson, Université d’Otago, Dunedin, Nouvelle Zélande
  • S.S. Apte, Lerner Research Institute, Cleveland, USA
  • André. Mégarbane, Université St Joseph, Beyrouth, Liban
  • Z.Q. Pan, Department of Oncological Sciences, Mount Sinai School of Medicine, Los Angeles, USA
  • Annick. Raas Rothschild, Hadassah Hebrew University, Jérusalem, Israël

Equipe Asma Smahi

  • Dr Gnamey : TOGO, Dysplasie ectodermique anhydrotique
  • Manolis PASPARAKIS, Université de Cologne, Allemagne: Mouse models of NFkB pathologies.
  • aleria URSINI, Institute of Genetics and Biophysics, Naples, Italy : Genetic and molecular analysis of IP
  • Dr Amal Said, Hôpital Merrakech , Maroc : Psoriasis
  • Dr Hamida Turki et Dr Slaheddine Marrakchi , Hôpital Sfax , Tunisie, Psoriasis
  • Shoji YAMAOKA, Department of Molecular Virology, Tokyo Medical and Dental University, Japon: Genetic and molecular analysis of NF-kB signaling

Equipe Laurence Colleaux

  • Nigel CARTER : Sanger Institute, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
  • Malika CHAOUCH, Hopital Ben Acknoun, Alger, Algérie
  • Josef GECZ, Department of Genetic Medicine, Women's and Children's Hospital, North Adelaide, Australia
  • Annick RAAS-ROTHSCHILD, Department of Human Genetics, HADASSAH University Hospital, Jerusalem, Israel
  • Orit REISH, Department of Medical Genetics, Assaf Harofeh, Israel
  • Patrick TARPEY : Cancer Genome Project, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK

Equipe Jean-Michel Rozet

  • Rando Allikmets: Department of Ophthalmology, Columbia University, New-York, USA
  • Shomi Bhattacharya: Institute of Ophthalmology, UCL, London, UK
  • Johanna Seddon: Massachusetts Eye and Ear Infirmary, Boston, USA
  • Enza Maria Valente: Neurogenetics Unit, CSS-Mendel Institute, Roma, Italy

Equipe Geneviève Gourdon

  • Darren Monckton, Glasgow, UK
  • Glenn Morris, UK: Anticorps Msh3.
  • Giuseppe Novelli, Annalisa Bota, Italie: essai préclinique de thérapie génique
  • Christopher Pearson, Toronto, CA: étude de l’implication de la réplication dans l’instabilité des triplets répétés CTG
  • Jack Puymirat, Québec, CA : Essais thérapeutiques avec vecteurs antisens, ribozyme et RNAi
  • Laura Ranum, USA: étude d’agrégats protéiques dans le système nerveux central des souris transgéniques
  • Hein te Riele, Amsterdam, NL
  • Maurice Swanson, USA: essai préclinique de thérapie génique
  • Ibtissam Walker, Lausanne, CH : études des anomalies des nerfs dans nos souris transgéniques
  • Bé Wieringa, Nimjegen, NL

Equipe Agnès Rötig

  • Orly Elpeleg, Hadassah Hospital, Jérusalem, Israël
  • ERANET CraniRare : Pr B Wollnik (Koeln Univ., Germany), Dr N Akarsu (Hacettepe Univ., Ankara, Turquie), Dr U Kayserili (Istanbul, Turquie), Dr D Wieczorek (Essen Univ., Germany).
  • ERANET Hirschsprung disease Consortium : Dr I Ceccherini (Genoa, Itaky) ; Dr S Borrego (Barcelona, Spain).

Equipe Olivier Danos

  • Robin Ali (Department of Ophtalmology, UCL, London)
  • Andrea Ballabio (Telethon Institute of Genetics and Medicine, Naples, Italie)
  • Mary Collins (Division of Infection and Immunity, University College London, London, UK)
  • Ronald Crystal (Cornell University, New York USA)
  • Kay Davies (Department of Physiology Anatomy and Genetics, Oxford University, Oxford UK)
  • John Hopwood (Department of Chemical Pathology, Women and Children Hospital, North Adelaide, Australie)
  • Robert Kotin (National Heart Blood and Lung Institute, Bethesda, USA)
  • David Linch (Hematology, UCL Cancer Institute, UCL, London)
  • Richard Mulligan (Harvard Medical School, Boston, USA)
  • Francesco Muntoni (Dubowitz Neuromuscular Centre, UCL Institute of Child Health, London, UK)
  • Amit Nathwani (Hematology, UCL Cancer Institute, University College London, London, UK)
  • Adrian Thrasher (UCL Institute of Child Health, London, UK)

Equipe Martine Le Merrer

  • Eurogentest (Belgique, Pr Cassiman)
  • Eurogene (Giovanni Romeo, R Stevens)